Wang Z, Bergeron N, Levison BS, Li XS, Chiu S, Jia X, et al
However, researchers and clinicians have observed its potential in a much broader population, especially in the context of: Visceral adiposity (deep belly fat) Growth hormone deficiency Cognitive aging Cardiometabolic risk reduction Its appeal lies in the ability to elevate IGF-1 (insulin-like growth factor-1) levels while preserving the bodys natural feedback mechanisms
GLP-1 Agonists GLP-1 agonists, such as semaglutide (Ozempic, Wegovy), have become incredibly popular for their powerful effects on weight loss
Topical applications may show initial improvements in skin texture and hydration within 2-4 weeks, with more significant changes in collagen production and skin firmness becoming apparent after 8-12 weeks of consistent use